Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Drug:  DI-Leu16-IL2 immunocytokine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-2 of 2 for your search:
Start Over
An Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Patients With B-cell Non-Hodgkin Lymphoma (NHL)
Phase: Phase II, Phase I
Type: Treatment
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Other
Protocol IDs: AO-101-EXT, NCT02151903
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: 03131, NCI-2010-01228, CDR0000598679, P50CA107399, CHNMC-03131, EMD-CHNMC-03131, NCT00720135
Start Over